Sigma Planning Corp - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 212 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
Sigma Planning Corp ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$63,000
-80.3%
13,500
-67.7%
0.00%
-77.8%
Q3 2021$319,000
+25.1%
41,840
+58.9%
0.01%
+12.5%
Q2 2021$255,000
+100.8%
26,330
+71.2%
0.01%
+100.0%
Q1 2021$127,000
+62.8%
15,380
+34.3%
0.00%
+33.3%
Q4 2020$78,000
-64.4%
11,450
-41.6%
0.00%
-66.7%
Q3 2020$219,000
+97.3%
19,610
-52.7%
0.01%
+50.0%
Q2 2019$111,000
-42.2%
41,500
+2.5%
0.01%
-45.5%
Q1 2019$192,000
+291.8%
40,500
+100.0%
0.01%
+175.0%
Q4 2018$49,000
-42.4%
20,250
+5.2%
0.00%
-20.0%
Q3 2018$85,000
-38.8%
19,2500.0%0.01%
-44.4%
Q2 2018$139,000
+85.3%
19,250
+32.8%
0.01%
+80.0%
Q1 2018$75,00014,5000.01%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders